IVERMECTIN IN THE TREATMENT OF COVID 19

Abstract

In late 2019, the emergence of a new coronavirus, called SARS-CoV-2, was announced, which is responsible for a pandemic that was decreed in March 2020 by the World Health Organization (WHO). Thus, there was a search for a molecule, already on the market, that could be an alternative treatment or even a cure for the virus. Thus, clinical research seeks to understand the use of drugs such as antivirals, antiparasitic, anti-malarials and, in this context, ivermectin, became the focus of several debates and divided opinions between scientists and health professionals. Therefore, this study aims to conduct a bibliographic research in order to understand how this drug acts to combat the SARS-CoV-2 virus, emphasizing the importance of these studies as a way of understanding the pandemic that changes in 2020.